[MYGN] YoY Quarter Result on 31-Mar-2014 [#Q1]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
07-May-2014
Financial Year
2014
Quarter
31-Mar-2014 [#Q1]
Profit Trend
QoQ- -26.99%
YoY- -2.96%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Revenue 196,900 190,500 179,985 182,924 156,472 129,777 102,374 11.50%
PBT 8,000 43,100 35,566 57,343 59,241 47,481 42,312 -24.22%
Tax 3,800 10,500 14,091 20,573 21,349 17,866 14,372 -19.86%
NP 4,200 32,600 21,475 36,770 37,892 29,615 27,940 -27.06%
Tax Rate -47.50% -24.36% -39.62% -35.88% -36.04% -37.63% -33.97% -
Total Cost 192,700 157,900 158,510 146,154 118,580 100,162 74,434 17.16%
Ratio Analysis
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
NP Margin 2.13 17.11 11.93 20.10 24.22 22.82 27.29 -34.60%
Per Share
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
EPS 0.06 0.49 0.30 0.50 0.47 0.35 0.32 -24.32%
EPS Diluted 0.06 0.47 0.29 0.48 0.46 0.34 0.31 -23.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.